Behavioral Economics may help find a balance between simplification of the underwriting process and the mitigation of risk.
Underwriting engines have been around for over 20 years. Initially they were used in head offices, processing application form information keyed in by clerical staff, and avoiding the need for (expensive) underwriters spending time on the more straightforward cases.
Quest continues to monitor COVID-19 and contribute to the scientific community’s understanding of this novel disease.
Many insurers currently look at substance use through a binary 'yes/no' lens
Dr. Tom Fletcher, VP, Data Analytics, North America Life, discusses the benefits of multidisciplinary teams.
While clinicians have a better understanding of COVID‑19 disease, science is still struggling to make sense of its long-lasting symptoms, known as Long COVID, and what “long haulers” have in common.
The U.S. hit a sad record in 2020, with deaths reaching more than 3 million for the first time.
When assessing glycemic control in the majority of our applicants, hemoglobin A1c is the gold standard for assessing glucose control over an intermediate period of time.
Insurers were already welcoming technology and embracing ideas such as accelerated underwriting. But things move slowly in the insurance world. Then the COVID-19 pandemic hit and insurers no longer controlled those timelines.